Dna XSONM
13F holders, Q2 2026 (June 30)9holders
1new positions
1sold out
1famous investor
$5.13avg. 13F price*
At the end of Q2 2026, 9 institutions reported holding Dna X Inc. (SONM) in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holders were C2C Wealth Management, LLC ($183K), BlackRock, Inc. ($72K) and Citadel Advisors ($65K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Dna X Inc.
- CUSIP
- 83548F408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $65K |
| Exits | 1 | $16 |
All 13F filers, Q1 2026 → Q2 2026: 29,249 shares bought and 36,156 shares sold, net −6,907 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| C2C Wealth Management, LLC | 0.14% | Add +77.5% | 35,500 | $183K |
| BlackRock, Inc. | 0.00% | No change | 14,006 | $72K |
| Citadel Advisors | 0.00% | New | 12,740 | $65K |
| Geode Capital Management, LLC | 0.00% | Reduce -15.0% | 12,584 | $64K |
| Vanguard Capital Management LLC | 0.00% | Add +20.6% | 5,901 | $30K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 4,496 | $23K |
| UBS Group AG | 0.00% | Reduce -93.6% | 2,304 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -2.9% | 642 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 214 | $1K |
"% of holder's portfolio" is SONM's weight in each manager's 13F, not the share of Dna X Inc. the manager owns.